Successful Treatment of Neuroleptic Malignant Syndrome With Bromocriptine
Abdorasool Janati, Roger T. Webb
Abstract
Abdorasool Janati, Roger T. Webb
Abstract
From our four cases, we conclude that prompt diagnosis, intensive care monitoring and support, and early use of bromocriptine can markedly reduce the duration of the symptom complex of neuroleptic malignant syndrome, as well as significantly improve the 20% mortality previously reported.
OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
From our four cases, we conclude that prompt diagnosis, intensive care monitoring and support, and early use of bromocriptine can markedly reduce the duration of the symptom complex of neuroleptic malignant syndrome, as well as significantly improve the 20% mortality previously reported.
Key concepts: Bromocriptine, Medicine, Neuroleptic malignant syndrome, Pediatrics, Intensive care medicine, Internal medicine, Prolactin, Hormone